Novocure is a private oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. Headquartered in Jersey Isle, Novocure’s US operations are based in Portsmouth, NH and New York, NY. Additionally, the company has offices in Switzerland and Japan and a research center in Haifa, Israel
Novocure is an overnight success story fourteen years in the making. Since 2000, the company has grown from one inspired man running experiments in his basement lab to the multinational commercial business it is today.